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Abstract
Background: Few studies have related nutritional factors with quality of life in healthy populations. The purpose of
the study was to assess whether dietary fat intake is associated to mental and physical quality of life.
Methods: This analysis included 8,430 participants from the SUN (Seguimiento Universidad de Navarra) Project. The
intake of saturated fatty acids (SFA), polyunsaturated fatty acids (PUFA), trans unsaturated fatty acids (TFA), and
monounsaturated fatty acids (MUFA) was assessed through a 136-item food frequency questionnaire at baseline.
Quality of life was measured with the SF-36 Health Survey after 4 years of follow-up. Generalized Linear Models
were fitted to assess the regression coefficients (b) and their 95% confidence intervals (95% CI) for the 8 domains
of the SF-36 according to successive quintiles of each kind of fatty acids intake.
Results: The multivariate-adjusted models revealed a significant inverse association for SFA intake (in quintiles) and
two of the physical domains (physical functioning and general health). E.g. for general health domain: (highest
quintile of intake (Q5) vs. lowest quintile (Q1), b = -1.6; 95% CI = -3.1, -0.1. General health also showed a dose-
response relationship (p for trend < 0.05). For TFA intake (in quintiles), a significant inverse association was found
for most of the mental domains (vitality, social functioning and role emotional). E.g. for vitality domain (Q5) vs.
(Q1), b = -2.0, 95% CI = -3.4 to -0.6. We also found an inverse association between TFA intake and the bodily pain
domain: (Q5 vs. Q1), b = -2.6; 95% CI = -4.4 to -0.8, with a statistically significant dose-response relationship (p for
trend < 0.05). Except for TFA intake and the mental domains, the rest of the associations were attenuated when
we repeated the analysis adjusting for adherence to the Mediterranean diet.
Conclusions: A detrimental relationship between TFA intake at baseline and most of the SF-36 mental domains
measured 4 years later were found, whereas weak inverse associations were found for SFA intake and some
physical domains.
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Background
Quality of life is a broad concept that relates to all
aspects of human life. Quality of life questionnaires have
become an efficient way of gathering data about people
functioning and well being. Also health status measures
have been shown to be a powerful predictor for chronic
diseases and mortality over the long term in clinical
practice [1,2]. Moreover, population ageing has fostered
the general concern for obtaining a better health-related
quality of life [3].
Epidemiological studies have shown the influence of
different factors such as smoking, obesity, or crash inju-
ries on quality of life [4-7]. However, few longitudinal
studies have analyzed the influence of diet on the quality
of life of healthy populations [8-10]. Several studies have
found that the adherence to a Mediterranean dietary
pattern rich in fruits and vegetables, legumes, fish and
olive oil, was associated with higher scoring for self-per-
ceived health [11,12]. On the other hand, some studies
have shown the detrimental effects on health of a “Wes-
tern-type” dietary pattern rich in processed and red
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[13-16]. The Western dietary pattern is the common
diet in Northern Europe and the USA. In recent years,
however, southern European countries, which used to
eat a traditional Mediterranean diet, have also been
a d o p t i n gam o r eW e s t e r n - s tyle diet. Beyond the health
effects of an overall Western dietary pattern, little is
known about the health effects of the diet’s specific ele-
ments, such as major fat sources, on quality of life.
T h e r eh a sb e e nad r a m a t i cc h a n g ei nt h es o u r c e so f
fat intake in the general population. This change mainly
consists in replacing polyunsaturated (PUFA) or mono-
unsaturated fatty acids (MUFA) with saturated fats
(SFA) and trans unsaturated fats (TFA). Usually, PUFA
[17] and olive oil (OO) [18-20] have been considered as
healthy lipids because they reduce the incidence of car-
diovascular disease (CVD). In contrast, SFA and espe-
cially TFA are known risk factors for CVD [21]. There
are some reasons to expect that CVD share some com-
mon determinants, [22] endothelial dysfunction and
high levels of pro-inflammatory cytokines, with other
pathologies like obesity, insulin resistance and neuropsy-
chological disorders. All of these physiological processes
may have also an influence on physical and mental qual-
ity of life in healthy population.
From a public health perspective, it is necessary to
identify the nutritional factors that could increase or
decrease the quality of life and health status of the
population. The aim of this study was to assess the asso-
ciation between dietary fat intake and self-perceived
health-related mental and physical quality of life in a
Mediterranean cohort, the SUN Project.
Methods
Study population
The “Seguimiento Universidad de Navarra’’ (SUN) Pro-
ject is an ongoing, multipurpose, dynamic cohort of uni-
versity graduates conducted in Spain and started in
December 1999. As a dynamic cohort, the recruitment
of the participants is permanently open. The study
methods and the cohort profile have been published in
detail elsewhere [23,24].
Information on exposures and outcomes is gathered
by postal mail or web-based questionnaires collected
biannually. Participants answer a baseline questionnaire
assessing multiple exposures such as nutritional habits,
physical exercise, medical conditions and other risk fac-
tors. Every two years they answer the follow-up ques-
tionnaires assessing changes in exposures and new
events of interest.
Up to November 2010, 15,089 participants had
responded to the baseline and to the 4-year follow-up
questionnaire. As the recruitment is permanently open,
with approximately 2,000 new participants each year,
only those entering the cohort before 2005 could be fol-
lowed-up for 4 years. The overall retention rate is 92%.
From those participants who were assessed after 4-year
(15,089), we excluded those who reported extremely low
or high values for total energy intake (less than 800
Kcal/day or more than 4,000 Kcal/day in men and less
than 500 Kcal or more than 3,500 Kcal/day in women
(n = 1,489), those who reported dyslipidemia and cardi-
ovascular disease at baseline (n = 2,924), and those with-
out or with incorrect data regarding quality of life (n =
2,246). Finally, 8,430 participants were included in this
analysis.
The study was approved by the Human Research Ethi-
cal Committee at the University of Navarra. Voluntary
completion of the first questionnaire was considered to
imply informed consent. Our Institutional Review Board
specifically approved this consent process.
Exposure assessment
Dietary intake was assessed using a semi-quantitative
food frequency questionnaire (136 food items) included
at baseline [25]. Validity and reproducibility of this
questionnaire has recently been re-evaluated [26]. It
showed reasonably good validity for assessing fat intake
(energy-adjusted intraclass correlation coefficients for
different types of fats versus four 3-day food records
ranged from 0.49 to 0.75) [27]. Nutrient intakes of 136
food items were calculated as frequency multiplied by
nutrient composition of specified portion size for each
food item, using an ad hoc computer program devel-
oped for this purpose. A trained dietician updated the
nutrient data bank using the latest available information
from the food composition table for Spain [28,29].
Baseline intake of every dietary fat: MUFA, n-3
PUFAs, n-6 PUFAs, SFA and TFA were analyzed as
quantitative variables (grams per day) and categorized
into quintiles. We also analyzed as quantitative variables
several culinary fats like seed oil, butter, margarine, and
olive oil and we categorized them into quintiles. Adjust-
m e n t sw e r em a d ef o rt o t a le n e r g yi n t a k eb yu s i n gt h e
r e s i d u a l sm e t h o dp r o p o s e db yW i l l e t[ 3 0 ] .T h er a t i on -
3/n-6 was also computed [31].
Outcome assessment
Quality of life was assessed after a 4-year follow-up with
the validated Spanish version of the SF-36 Health Sur-
vey. The SF-36 is a general health scale widely used and
thoroughly validated [32]. The questionnaire contains 36
items that measure eight multi-item parameters of
health status: physical functioning, role limitations due
to physical health problems (role-physical), bodily pain,
general health perceptions, vitality, social functioning,
role limitations due to emotional problems (role emo-
tional) and mental health. Domains 1 to 4 of the
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5 to 8 measure psychological features. For each para-
meter, scores were coded, summed and transformed to
a scale from 0 (the worst possible condition) to 100 (the
best possible condition). For example, for bodily pain a
score of 100 means a complete tolerance to pain.
Covariate assessment
The baseline assessment also gathered information on
socio-demographic variables (e.g. sex, age, marital status
and employment status), anthropometric variables (e.g.,
weight and height), lifestyle and health-related habits (e.
g., smoking status), and medical history (e.g., chronic
diseases) [24]. Self-reported body mass index (BMI) was
calculated as weight (in kilograms) divided by the square
of height (in meters). Self-reported anthropometrics
were previously been validated in a subsample of the
cohort [33].
At baseline, participants also completed a validated
physical activity questionnaire that collects information
about 17 activities [34]. Leisure-time activities were
computed by assigning an activity metabolic equivalent
(MET) score to each activity, multiplied by the time
spent in each activity and summing up all activities [35].
Information about alcohol intake was obtained
through the semi-quantitative food frequency question-
naire included in the baseline questionnaire.
Adherence to the Mediterranean diet was assessed
combining 8 items (fruits and nuts, vegetables, fish,
legumes, cereals, meat and meat products, dairy and alco-
hol intake) [36]. To avoid overlapping with our main
exposure, we excluded the ratio MUFA/SFA item from
this score (the actual range in our study was from 0 to 8).
Statistics
Generalized Linear Models were used to assess the rela-
tionship between quintiles of total fat and specific diet-
ary fatty acids intake and each domain of the SF- 36
Health Survey, using always the lowest quintile as the
reference. Regression coefficients (b) and their 95% con-
fidence intervals (95% CI) were calculated. Tests of lin-
ear trend across successive quintiles were conducted by
assigning the medians to each quintile and treating this
consumption as a continuous variable.
Age (years, continuous), sex, BMI at baseline (Kg/m
2),
total energy intake (Kcal/day, continuous), physical
activity during leisure time (METS- h/week, continuous)
and smoking (never, ex smokers and current smokers)
were considered as potential confounders in all the
models. To further reduce potential confounding, all
others fatty acids not considered as exposure variable
were also include as covariates in the models. Finally,
additional adjustments were made to take into account
Mediterranean diet-pattern adherence.
The SPSS software package for Windows version 18.0
(SPSS Inc., Chicago, IL) was used for statistical analyses.
Results
The main characteristics of the study population accord-
ing to extreme quintiles of SFA, TFA, MUFA and PUFA
intake are shown in Table 1. Younger participants, men
and current smokers were more likely to belong to the
highest level of SFA and TFA intake (Q5). Participants
in Q5 were also less active compared to those in the
lowest quintile (Q1). The adherence to the Mediterra-
nean diet score decreased across quintiles of SFA, TFA,
MUFA and PUFA intake. This decrease in the score is
lower for quintiles of MUFA and PUFA intake.
Table 2 shows the multivariate regression coefficients
(b) and their 95% CI for the mental domains of the SF-
36 according to baseline SFA and TFA intake (in quin-
tiles). The multivariate-adjusted model revealed a signifi-
cant inverse association between TFA intake and most
of the mental domains (vitality, social functioning and
role emotional). For example: b = -2.0, 95% CI = -3.4 to
-0.6 (Q5 vs. Q1), for the vitality domain. Moreover a
statistically significant dose-response relationship (p for
trend < 0.05) was found for each domain except for
mental health. No association was found for SFA intake
and the mental domains.
Multivariate regression coefficients and their 95% CI
for the physical domains of the SF-36 according to base-
line SFA and TFA intake (in quintiles) are shown in
Table 3.
For SFA intake, a significant inverse association was
found for physical functioning, and general health
domains. For the general health domain: (Q5 vs. Q1), b
= -1.6; 95% CI = -3.1 to -0.1. General health also
showed a statistically significant dose -response relation-
ship (p for trend < 0.05). For TFA, an inverse associa-
tion was found for bodily pain: (Q5 vs. Q1), b = -2.6;
95% CI = -4.4 to -0.8 with a dose-response relationship
(p for trend < 0.05).
When we repeated the analysis additionally adjusting
for the adherence to a Mediterranean diet score, the
association remained significant for TFA intake and the
mental domains and bodily pain.
No association was observed between n-3 PUFAs, n-6
PUFAs, MUFA or the ratio n-3 vs.n - 6i n t a k ea n dt h e
SF-36 domains. Neither was found for seed oils, butter,
margarine or olive oil (data not shown).
Discussion
The present study showed a harmful association
between the highest intake of TFA and several SF-36
domains. The association remained significant for the
mental domains (except for mental health), and bodily
pain after controlling for potential cofounders including
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association for SFA intake and some of the physical
domains was also found, although after adjusting for the
adherence to the Mediterranean diet score this relation-
ship was not statistically significant.
These associations could mean that the physiological
changes that occur when this kind of fatty acid is con-
sumed could influence mostly the mental quality of life
and therefore the self perception of “well being”. So, the
participants with the highest intake would perceive
themselves more tire and worn out, with social and role
disability due to emotional problems, and with severe
limiting pain than the participants with the lowest TFA
intake. Although these are perceived health measures
rather than biological measures, self-related heath status
has been shown to be a powerful predictor of mortality
at long term [2].
On the other hand, for the mental quality of life
domains, the magnitude of the differences between the
lowest and highest quintile of TFA intake were about
1.5-3 points. There is a debate on how to define mean-
ingful differences on the SF-36 scores in a clinical set-
ting. Changes in 3-, 5-, and 10- points have been
suggested as being clinically significant for clinical popu-
lations [37]. Given the characteristics of our cohort that
did not include patients, but healthy and relatively
young adults, the practical significance of these differ-
ences could be even higher. Although few studies have
examined this issue directly, several investigators have
raised the question of whether individuals with more
severe impairments in HRQOL require a greater change
to be considered meaningful than those with less severe
impairments [38].
Fatty acids of trans configuration come from two main
different sources: the major source is derived from
industrially produced partially hydrogenated fat used in
margarines, commercial cooking, and manufacturing
processes (60% of the fats), and smaller amounts are
naturally present in dairy and meat products from rumi-
nants (6% of the fats) [39]. Based on the evidence to
date, TFA intake, particularly the industrial trans-18:2
isomer, is associated with substantial risk of coronary
heart disease (CHD) [40-43]. The adverse effects of TFA
on CVD are thought to be mediated by increases in
plasma concentrations of LDL-cholesterol, reductions in
HDL-cholesterol, pro-inflammatory changes, endothelial
dysfunction, and possibly by insulin resistance and dis-
placement of essential fatty acids from membranes
[44,45].
The relation of TFA intake to other disease outcomes
has been examined less extensively than for CHD. How-
ever, emerging evidence suggests that TFA acid intake
may influence additional non -lipid related pathways
and outcomes. These include effects on systemic inflam-
mation, endothelial dysfunction, visceral adiposity, insu-
lin resistance, and arrhythmic risk [46]. Moreover, TFA
intake has been linked to accelerated cognitive decline
in older adults [47], and higher risk of Alzheimer [48],
and depression [49]. The harmful effect of TFA intake
in these neuropsychological disorders supports our
results which suggest that TFA intake specially affects
mental quality of life. A possible explanation for our
finding is that TFA promote endothelial dysfunction
and increase the production of pro-inflammatory cyto-
kines that may interfere with neurotransmitter metabo-
lism and inhibit Brain-derived neurotrophic factor
Table 1 Baseline characteristics* according to extreme quintiles of specific types of fat intake in the SUN project.
Characteristic Saturated fat Trans unsaturated fat MUFA fat PUFA fat
Q1 Q5 Q1 Q5 Q1 Q5 Q1 Q5
Sex (% men) 37.7 41.1 34.5 43.8 42.9 28.8 36.8 38.8
Age at baseline (y) 39.4 (11.9) 34.6 (9.9) 38.9 (11.6) 35.1 (10.2) 38.4 (12.0) 36.2 (10.6) 37.8 (11.2) 35.3 (10.9)
BMI (kg/m
2) 23.4 (3.3) 23.0 (3.3) 23.2 (3.3) 23.0 (3.3) 23.3 (3.2) 23.0 (3.3) 23.1 (3.3) 22.9 (3.3)
Smoking:
Ex smoker (%) 30.4 22.7 30.6 22.0 26.9 29.2 29.1 26.0
Current (%) 19.9 25.3 20.3 23.5 19.7 26.0 21.6 23.2
Leisure time physical activity (Mets-h/wk) 23.6 (25.9) 19.3 (24.1) 23.6 (25.8) 19.1 (21.8) 23.4 (26.4) 19.0 (21.7) 23.2 (27.1) 18.8 (21.3)
Total energy intake (Kcal/d) 2537 (581) 2495 (616) 2616 (551) 2508 (594) 2534 (577) 2503 (610) 2617 (517) 2519 (616)
Mediterranean Dietary Score (0-8) 4.9 (1.4) 2.8 (1.4) 4.8 (1.4) 2.9 (1.5) 4.5 (1.5) 3.4 (1.6) 4.3 (1.6) 3.8 (1.6)
Total fat intake (g/d)* 80.4 (15.9) 113.7 (13.7) 87.8 (19.3) 107.4 (15.1) 77.0 (12.6) 118.5 (12.9) 84.1 (17.4) 108.7 (16.1)
Saturated fat intake (g/d)* 22.8 (4.2) 45.5 (6.4) 25.8 (6.8) 42.0 (8.4) 26.4 (6.3) 39.2 (9.3) 31.0 (9.8) 34.8 (8.4)
Monounsaturated fat intake (g/d)* 34.5 (9.4) 48.4 (8.5) 38.5 (11.6) 45.0 (8.6) 29.6 (4.6) 56.0 (7.3) 35.2 (8.7) 46.0 (10.2)
Polyunsaturated fat intake (g/d)* 12.9 (5.1) 14.6 (4.3) 13.5 (5.3) 14.3 (4.1) 11.6 (4.2) 16.2 (4.9) 9.0 (1.7) 20.5 (4.0)
Trans unsaturated fat intake (g/d)* 0.6 (0.3) 1.5 (0.6) 0.4 (0.2) 1.7 (0.4) 0.8 (0.4) 1.2 (0.6) 0.9 (0.6) 1.0 (0.5)
*Continuous variables are expressed as the mean and (standard deviation). Categorical variables are expressed as percentages.
MUFA: Monounsaturated fatty acid. PUFA: Polyunsaturated fatty acid. Q1: First quintile (lowest intake). Q5: Fifth quintile (highest intake)
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[50,51]. BDNF is a peptide critical for axonal growth,
neuronal survival and synaptic plasticity and function.
Therefore, it is likely that the consumption of foods
containing TFA in their composition could increase the
vulnerability to some mental or neurological disorders
or act negatively on mental quality of life.
Although our results suggest a detrimental role of
TFA on mental quality of life, our findings are mod-
e s t .T h ep r e s e n ts t u d yw a sc a r r i e do u ta m o n gas a m -
ple in which TFA intake was very low (the median of
intake was 1 gram per day). This intake was lower
than the median intake for Spanish population which
is 2.1 grams per day, [52] and far away from the
higher consumption corresponded to the United
States and Canada with values of 3-4 grams per day
[ 5 3 ] .T h e r e f o r e ,t h er e p e r c u s s i o no ft h e s ef i n d i n g s
might be really important in these populations where
the consumption is very high comparing to our
cohort and where the main sources of TFA are artifi-
cial foods [54].
Several limitations in our study have to be addressed.
Diet was ascertained at baseline and quality of life after
4-years of follow-up, therefore we acknowledge that
baseline scores of quality of life were unknown. Conse-
quently, in spite of the fact that the follow-up of partici-
pants allows a sufficient long induction period, it could
still be possible to speculate that a poor-quality diet may
Table 2 Regression coefficients (b) and 95% Confidence Intervals (CI) for the association between baseline saturated
(SFA) and trans unsaturated (TFA) fatty acid intake and the SF-36 mental domains after 4-y follow-up.
Baseline saturated fatty acid intake
SF-36 mental scores after 4 years of follow-up Q1 Q2 Q3 Q4 Q5 p linear trend
Energy-adjusted SFA intake (g/day) (median) 22.8 29.7 33.5 37.3 45.5
Vitality
Multivariate adjusted model (1) 0 (ref.) -0.7 (-1.8, 0.5) -0.2 (-1.4, 1.0) -0.2 (-1.5, 1.1) -1.4 (-2.9, 0.1) 0.166
Additionally adjusted for MD (2) 0 (ref.) -0.4 (-1.6, 0.7) 0.2 (-1.0, 1.4) 0.2 (-0.9, 1.7) -0.7 (-2.2, 0.9) 0.682
Social functioning
Multivariate adjusted model (1) 0 (ref.) 0.3 (-0.7, 1.3) 1.0 (-0.02, 2.1) 0.6 (-0.5, 1.6) -0.3 (-1.7, 1.0) 0.779
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-0.7, 1.3) 1.1 (-0.09, 2.2) 0.7 (-0.5, 1.9) -0.6 (-1.6, 0.5) 0.924
Role emotional
Multivariate adjusted model (1) 0 (ref.) 1.8 (-0.2, 3.8) 2.3 (0.2, 4.5) 3.0 (0.7, 5.2) 2.0 (-0.7, 4.7) 0.099
Additionally adjusted for MD (2) 0 (ref.) 1.9 (-0.2, 3.8) 2.3 (0.1, 4.4) 3.0 (0.7, 5.3) 2.1 (-0.6, 4.9) 0.099
Mental health
Multivariate adjusted model (1) 0 (ref.) 0.3 (-0.7,1.2) 0.7 (-0.3, 1.6) 0.5 (-0.4, 1.5) -0.7 (-1.9, 0.6) 0.520
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-0.7, 1.2) 0.6 (-0.4, 1.6) 0.5 (-0.5, 1.6) -0.7 (-1.9, 0.7) 0.530
Baseline trans unsaturated fatty acid intake
Energy-adjusted TFA intake (g/day) (median) 0.4 0.8 1.0 1.2 1.7
Vitality
Multivariate adjusted model (1) 0 (ref.) -1.3 (-2.4, -0.2) -0.6 (-1.8, 0.5) -0.2 (-1.8, 0.6) -2.0 (-3.4, -0.6) 0.056
Additionally adjusted for MD (2) 0 (ref.) -1.2 (-2.3, -0.1) -0.4 (-1.6, 0.7) 0.1 (-1.1, 1.3) -1.6 (-3.0, -0.2) 0.162
Social functioning
Multivariate adjusted model (1) 0 (ref.) -0.4 (-1.4, 0.6) -0.2 (-1.3, 0.8) -0.2 (-1.3, 0.8) -1.7 (-2.9, -0.5) 0.013
Additionally adjusted for MD (2) 0 (ref.) -0.5 (-1.5, 0.6) -0.2 (-1.3, 0.8) -0.2 (-1.3, 0.8) -1.7 (-2.9, -0.4) 0.017
Role emotional
Multivariate adjusted model (1) 0 (ref.) 0.2 (-1.8, 2.2) 0.3 (-1.8, 2.4) 0.4 (-1.8, 2.4) -3.5 (-6.0, -1.0) 0.006
Additionally adjusted for MD (2) 0 (ref.) 0.1 (-1.9, 2.1) 0.2 (-1.9, 2.3) 0.4 (-1.8, 2.6) -3.5 (-6.0, -1.0) 0.007
Mental health
Multivariate adjusted model (1) 0 (ref.) -0.3 (-1.3, 0.6) -0.1 (-1.1, 1.0) 1.0 (-0.1, 2.1) -0.2 (-1.4, 1.1) 0.646
Additionally adjusted for MD (2) 0 (ref.) -0.3 (-1.3, 0.7) -0.1 (-1.2, 0.9) 0.9 (-0.2, 2.0) -0.2 (-1.4, 0.7) 0.634
The SUN cohort 1999-2010.
Vitality: vitality and energy feelings against tiredness or exhaustion
Social Functioning: grade in which mental health problems can interfere with habitual social life
Role Emotional: grade in which mental health problems can interfere with work activity or with other daily activities
Mental Health: general mental health including depression, anxiety, emotional and behaviour control and general positive effect
(1): Model adjusted for age, sex, smoking (non smoker, current, ex-smoker and missing value), leisure time physical activity (in quintiles of METs-h/wk score), total
energy intake (Kcal/day), and baseline BMI (Kg/m
2), MUFA, PUFA and, additionally, SFA (TFA intake) or TFA (SFA model).
(2): Model 1 additionally adjusted for adherence to the Mediterranean Diet score (0-8) (excluding SFA/MUFA ratio).
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causal factor.
We acknowledge that although the food frequency
questionnaire has been validated using dietary records
as gold standard, this is not the best method to validate
some dietary fatty acids intake such n-3 PUFAs. The use
of a validation method with biomarkers as gold standard
is recommended. This could lead to certain, probably
non-differential, misclassification bias in the dietary n-3
PUFAs assessment.
Another fact to take into account is that quality of life
is a complex concept with various dimensions. Never-
theless, the use of the SF-36 questionnaire for evaluating
the physical and mental dimensions of quality of life is
generally accepted, and its validity and reliability have
been demonstrated in many population-based studies
[55].
Some strengths of our study also deserve to be men-
tioned. They include its large sample size, its long-term
follow-up, the multiple adjustments of our estimates for
a variety of major potential confounders, the existence
of published validation studies of our assessments, and
the restriction to highly educated participants, which
provides a better validity to the self-reported data.
Conclusion
In summary, our findings suggest that TFA is the fat
subtype that adversely affects quality of life. This
Table 3 Regression coefficients (b) and 95% Confidence Intervals (CI) for the association between baseline saturated
(SFA) and trans unsaturated fatty (TFA) acid intake and the SF-36 physical domains after 4-y follow-up.
Baseline saturated fatty acid intake
SF-36 physical scores after 4 years of follow-up Q1 Q2 Q3 Q4 Q5 p linear trend
Energy-adjusted SFA intake (g/day) (median) 22.8 29.7 33.5 37.3 45.5
Physical functioning
Multivariate adjusted model (1) 0 (ref.) 0.2 (-0.5, 0.8) -0.04(-0.7, 0.6) -0.6 (-1.3, 0.1) -1.0 (-1.9, -0.2) 0.520
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-0.4, 0.9) 0.1 (-0.5, 0.8) -0.3 (-1.0, 0.4) -0.7 (-1.5, 0.2) 0.068
Role physical
Multivariate adjusted model (1) 0 (ref.) 0.1 (-1.8, 2.0) 0.8 (-1.2, 2.8) 1.1 (-1.0, 3.2) -1.7 (-4.2, 0.9) 0.384
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-1.5, 2.2) 1.2 (-0.8, 3.2) 1.6 (-0.6, 3.7) -1.1 (-3.7, 1.5) 0.676
Bodily pain
Multivariate adjusted model (1) 0 (ref.) 0.1 (-1.3, 1.6) 0.4 (-1.1, 2.1) 0.4 (-1.2, 2.0) -0.6 (-2.5, 1.3) 0.664
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-1.2, 1.7) 0.7 (-0.9, 2.3) 0.9 (-0.8, 2.5) 0.03 (-2.1, 2.0) 0.831
General health
Multivariate adjusted model (1) 0 (ref.) 0.2 (-0.9, 1.3) -0.1 (-1.2, 1.1) -0.5 (-1.8, 0.8) -1.6 (-3.1, -0.1) 0.027
Additionally adjusted for MD (2) 0 (ref.) 0.3 (-0.8, 1.5) 0.3 (-1.0, 1.5) -0.02 (-1.3, 1.3) -1.0 (-2.5, 0.6) 0.206
Baseline transunsaturated fatty acid intake
Energy-adjusted TFA intake (g/day) (median) 0.4 0.8 1.0 1.2 1.7
Physical functioning
Multivariate adjusted model (1) 0 (ref.) -0.4 (-1.0, 0.2) 0.2 (-0.5, 0.8) -0.1 (-0.8, 0.6) -0.8 (-1.5, 0.02) 0.111
Additionally adjusted for MD (2) 0 (ref.) -0.4 (-1.0, 0.2) 0.2 (-0.4, 0.9) -0.02 (-0.7, 0.7) -0.6 (-1.4, 0.2) 0.289
Role physical
Multivariate adjusted model (1) 0 (ref.) -0.8 (-2.6, 1.1) 0.09 (-1.9, 2.0) -1.0 (-3.0, 1.1) -2.3 (-4.6, 0.04) 0.050
Additionally adjusted for MD (2) 0 (ref.) -0.7,(-2.5, 1.2) 0.3 (-1.7, 2.2) -0.8 (-2.8, 1.3) -2.0 (-4.4, 0.3) 0.085
Bodily pain
Multivariate adjusted model (1) 0 (ref.) -1.9 (-3.4, -0.5) -1.2 (-2.7, 0.3) -1.8 (-3.4, -0.2) -2.6 (-4.4, -0.8) 0.017
Additionally adjusted for MD (2) 0 (ref.) -1.9 (-3.4, -0.5) -1.1 (-2.6, 0.4) -1.6 (-3.2, -0.1) -2.3 (-4.1, -0.5) 0.042
General health
Multivariate adjusted model (1) 0 (ref.) -0.03 (-1.2, 1.1) 1.3 (0.1, 2.5) 0.6 (-0.6, 1.9) -1.1 (-2.5, 0.3) 0.161
Additionally adjusted for MD (2) 0 (ref.) 0.02 (-1.1, 1.1) 1.5 (0.3, 2.7) 0.9 (-0.4, 2.1) -0.8 (-2.2, 0.6) 0.367
The SUN cohort 1999-2010.
Physical Functioning: grade in which health problems can interfere with physical activities such as walking, self-care or weight lifting
Role Physical: grade in which physical health problems can interfere with work activity or with other daily activities
Bodily Pain: pain intensity and its effect on work inside and outside home
General Health: personal belief regarding current health and future perspectives regarding health
(1): Model adjusted for age, sex, smoking (non smoker, current, ex-smoker and missing value), leisure time physical activity (in quintiles of METs-h/wk score), total
energy intake (Kcal/day), and baseline BMI (Kg/m
2), MUFA, PUFA and, additionally, SFA (TFA intake) or TFA (SFA model).
(2): Model 1 additionally adjusted for adherence to the Mediterranean Diet score (0-8) (excluding SFA/MUFA ratio).
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Page 6 of 8association was stronger for the mental domains than
for the physical domains of the SF-36. However, replica-
tion of these findings in prospective studies, including
also a baseline ascertainment on quality of life scores is
required in order to confirm the reported associations
and their direction.
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